Dysferlinopathy
Information
- Disease name
- Dysferlinopathy
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT01676077 | Active, not recruiting | Clinical Outcome Study for Dysferlinopathy | September 2012 | March 2024 | |
| NCT00527228 | Completed | Phase 2/Phase 3 | Deflazacort in Dysferlinopathies | September 2003 | September 2008 |
| NCT02710500 | Completed | Phase 1 | rAAVrh74.MHCK7.DYSF.DV for Treatment of Dysferlinopathies | March 2016 | July 2019 |
| NCT04824040 | Enrolling by invitation | Clinical, Immunological, Morphological and Genetic Characteristics of Patients With Dysferlinopathy in the RF | January 15, 2020 | July 2024 | |
| NCT01863004 | Terminated | Phase 1 | Proteasomal Inhibition for Patients With Mis-sense Mutated Dysferlin | December 2012 | September 15, 2017 |